FDA advisory panel votes overwhelmingly towards MDMA remedy for PTSD
In an incredibly robust rejection of the primary psychedelic remedy to return prior to the Meals and Drug Management, a systematic advisory panel on Tuesday overwhelmingly voted towards the usage of MDMA